Clinical trials
Recruiting Observational trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
163 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 7 |
| 2022 | 13 |
| 2023 | 22 |
| 2024 | 18 |
| 2025 | 40 |
| 2026 | 25 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 163 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Charles University, Czech Republic | 12 |
| University Hospital Ostrava | 12 |
| Masaryk University | 6 |
| The Institute of Molecular and Translational Medicine, Czech Republic | 6 |
| University of Alberta | 6 |
| General University Hospital, Prague | 5 |
| Institute for Clinical and Experimental Medicine | 5 |
| St. Anne's University Hospital Brno, Czech Republic | 5 |
| Biotronik SE & Co. KG | 4 |
| Genzyme, a Sanofi Company | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 9 |
| Neoplasms | 7 |
| Atrial Fibrillation | 5 |
| Bradycardia | 4 |
| Critical Illness | 3 |
| Disease | 3 |
| Endometrial Neoplasms | 3 |
| Endometriosis | 3 |
| Frailty | 3 |
| Friedreich Ataxia | 3 |
Trials
Showing 1 to 25 of 163. Each trial links to its page on Pharma Observatory.
63 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.